Contents
Editor’s Letter
What to look forward to in GaBI Journal, 2022, Issue 2
Commentary
Substitution and interchangeability: time for a conversation?
Original Research
On statistical evaluation for interchangeability of biosimilar products
A case study of AstraZeneca’s omeprazole/esomeprazole chiral switch strategy
Review Article
Sponsored Article
Front-loading biosimilar development with analytical characterization